Skip to content
★ Sign in to follow
VS

Veena Singh

Executive
Biocept Inc
Total declarations
5
Company
1
▲ Purchases (3 ops.)
€24k
▼ Sales (0 ops.)
—

Latest filing published 02 Jun 2017 for BIOCEPT INC.

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Veena Singh: trading record in brief

Veena Singh is a declared insider of Biocept Inc, with filings sourced from SEC (Form 4). In total, 5 filings cover trades dated from 29 May 2015 to 31 May 2017.

Purchases make up the whole of the open-market record (3 purchases, €24k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants.

In size, the median ticket on the buying side is €9,082.

The newest entry dates from 2 June 2017: a share grant, in Biocept Inc. The clock since the last published purchase (21 October 2016) now reads 3,670 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Veena Singh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ◆
    Sr VP & Sr Med DirectorExecutivesBiocept Inc
    0SEC
    25,000 shares0Common StockSEC:0001209191-17-037208:0
  • ▲
    Sr VP & Sr Med DirectorExecutivesBiocept Inc
    11,000 USD37SEC
    10,000 shares@ US$1.10100.0% of flowCommon StockSEC:0001209191-16-146636:0
    Canonical exit: 17 Jan 2017 (T+90)
  • ◆
    Sr VP & Sr Med DirectorExecutivesBiocept Inc
    0SEC
    50,000 shares0Common StockSEC:0001209191-16-132032:0
  • ▲
    Sr VP & Sr Med DirectorExecutivesBiocept Inc
    5,490 USD0SEC
    1,800 shares@ US$3.05Common StockSEC:0001209191-15-048762:0
    Canonical exit: 27 Aug 2015 (T+90)
  • ▲
    Sr VP & Sr Med DirectorExecutivesBiocept Inc
    9,920 USD0SEC
    3,200 shares@ US$3.10Common StockSEC:0001209191-15-048762:1
    Canonical exit: 30 Aug 2015 (T+90)

5 of 5 declarations